April 16, 2021
Via: medicaldevice-network.comAbiomed has enrolled the first patient in the PROTECT IV trial, which aims to obtain the clinical evidence needed to get a Class I guideline recommendation for Impella heart pumps in high-risk percutaneous coronary intervention (HRPCI). The first patient was […]
June 28, 2016
Via: MedgadgetScientists at the École polytechnique fédérale de Lausanne (EPFL) in Switzerland have developed a completely new type of heart pump that does not make any contact with the blood that it’s augmenting. There’s a number of pumps on the market, […]
July 19, 2024
Copyright © 2024. All rights reserved
